家族性良性天疱疮ATP2C1基因突变研究

目的 探讨家族性良性天疱疮5个散发病例的ATP2C1基因突变.方法 5例来自门诊的散发病例,采集外周血,提取基因组DNA,采用PCR和DNA直接测序的方法,检测5个散发家族性良性天疱疮患者的ATP2C1基因突变,在100例正常人对照中予以验证.结果在5例具有典型临床表现,经皮肤病理和免疫病理确诊的散发家族性良性天疱疮患者,检测到5个未曾报道的ATP2C1基因突变位点,包括1个缺失突变(2025delG),3个错义突变(L269R,C348R,A651D),和1个无义突变(Q259x).100例正常人对照中均未检测到上述突变.结论 发现家族性良性天疱疮新的ATP2C1基因突变位点.     

家族性良性天疱疮ATP2C1基因突变研究

目的 探讨家族性良性天疱疮5个散发病例的ATP2C1基因突变.方法 5例来自门诊的散发病例,采集外周血,提取基因组DNA,采用PCR和DNA直接测序的方法,检测5个散发家族性良性天疱疮患者的ATP2C1基因突变,在100例正常人对照中予以验证.结果在5例具有典型临床表现,经皮肤病理和免疫病理确诊的散发家族性良性天疱疮患者,检测到5个未曾报道的ATP2C1基因突变位点,包括1个缺失突变(2025delG),3个错义突变(L269R,C348R,A651D),和1个无义突变(Q259x).100例正常人对照中均未检测到上述突变.结论 发现家族性良性天疱疮新的ATP2C1基因突变位点.     

家族性良性天疱疮患者ATP2C1基因突变研究

目的 探讨3个家族性良性天疱疮家系和1例散发患者的ATP2C1基因突变。方法 采取家系中患病成员外周血,应用外周血细胞DNA抽提、PCR扩增和DNA直接测序等方法检测ATP2C1基因突变情况,用反向测序验证突变,用100例无血缘关系个体作正常人对照。结果 在2个家族性良性天疱疮家系和1例散发患者中发现3个未曾报道的错义突变。家系1第20外显子2048位碱基G→A,导致错义突变R619K;家系2第8外显子853位碱基A→C,导致错义突变T221P;散发患者第23外显子2323位碱基T→C,导致错义突变Y711H。家系中非患病成员和100例无血缘关系正常人均未发现这些改变。在1个家族性良性天疱疮家系未检测到基因突变。结论 发现家族性良性天疱疮3种新的ATP2C1基因突变位点。     

家族性良性天疱疮基因突变研究

目的 探讨家族性良性天疱疮17个先证者的ATP2C1基因突变。方法 采用PCR和DNA直接测序的方法，检测17个家族性良性天疱疮先证者的ATP2C1基因外显子区。结果 在9个先证者中检测到8个不同的ATP2C1基因突变位点，包括3个缺失突变（nt1464-1487／1462-1485del，1523delAT和2375delTTGT），3个剪接位点突变（360-2A→G，1415-2A→T和2243＋2T→C）及2个错义突变（P307L和D648Y）。120例正常人对照中均未检测到上述几种突变。结论 此8个ATP2C1基因突变是该病新的特异突变。     

一个家族性良性天疱疮致病基因的新突变位点

目的 对一个中国人家族性良性天疱疮（HHD）家系进行ATP2C1基因突变检测。方法 调查一个HHD家系3代9人,其中2例具有HHD的临床表现。收集该家系所有成员的外周血,提取基因组DNA,采用PCR扩增ATP2C1基因的27个外显子,用直接测序法进行DNA测序分析。同时设立100例无亲缘关系的正常人作为对照。 结果 在该家系的2例患者中均检测到1个尚未报道过的ATP2C1基因错义突变位点（M 661 R）。在该家系健康个体及无亲缘关系的正常对照均未发现相同突变。结论 在该HHD家系中发现ATP2C1基因一个新的特异性突变位点（M 661 R）。     

家族性良性慢性天疱疮ATP2C1基因突变检测

目的:检测家族性良性慢性天疱疮ATP2C1基因突变.方法:提取20例患者和100例健康对照者的外周血DNA,采用聚合酶链反应(PCR)扩增ATP2C1基因的全部外显子,用直接测序法进行DNA测序,检测ATP2C1基因突变.结果:20例患者中检测到9种突变,包括4种缺失突变(167或168de1C,2374delTTTG,2454delT,2558delTGGGACAATT),3种错义突变(I711R,Q737R,1580V),2种无义突变(R55X,R799X),健康对照者中未检测到上述突变.其中167或168de1C,2454delT,2558de1T-GGGACAATT,I711R,Q737R为新发现的突变位点.结论:家族性良性慢性天疱疮存在遗传异质性.     

慢性家族性良性天疱疮五家系ATP2C1基因突变分析

目的：检测中国汉族慢性家族性良性天疱疮5家系ATP2C1基因突变情况。方法：提取5家系中12例患者、13名表型正常及100名正常对照外周血基因组DNA，经PCR扩增后进行DNA测序，并使用Chromas软件解析。结果：家系1中3例患者存在ATP2C1基因第18号外显子c.1738A>G（p.I580V）突变，家系2 中2例患者存在ATP2C1基因第25号外显子c.2416C>T(p.R806*)突变，家系3中3例患者存在ATP2C1基因第15号外显子c.1250G>A（p.R417K）突变，家系4和家系5 中ATP2C1基因未发现突变。上述家系内表型正常个体及100名正常对照中均未检测到相应突变。结论：ATP2C1基因突变可能在3例汉族HHD家系内发挥致病作用。     

家族性良性慢性天疱疮基因诊断1例

目的:检测一家族性良性慢性天疱疮患者子代ATP2C1基因突变.方法: 应用DNA直接测序的方法对一已经检测到基因突变的家族性良性慢性天疱疮患者的子代进行突变检测,以对患者第三代进行产前咨询.结果:在其子代未发现相同的突变位点.结论: 可以预测患者第三代不会患有家族性良性慢性天疱疮.     

一婴儿期发病的慢性家族性良性天疱疮家系ATP2C1基因突变研究

目的 对一慢性家族性良性天疱疮家系进行测序,寻找ATP2C1基因外显子上的突变点,丰富关于ATP2C1基因突变的信息。方法 提取一慢性家族性良性天疱疮家系中先证者及包括其父母、舅舅在内的家族中6名其他成员的外周血DNA进行测序,与人类基因组ATP2C1序列相比较找出突变点,另外测50例正常人血的ATP2C1基因,除外单核苷酸多态性。结果 家系中先证者、其舅舅及其母亲在ATP2C1的第9外显子上存在一杂合性的剪切突变,第699位缺失腺嘌呤（A）,导致其下游第12位的氨基酸序列出现终止密码TGA。反向测序亦证实该突变。该家系中先证者父亲、其他3名成员及50例正常人均未见该突变。结论 本研究慢性家族性良性天疱疮家系中先证者及其母亲及舅舅ATP2C1的第9外显子上存在一杂合性的剪切突变,突变来自于母系并向下遗传。     

一家族性良性天疱疮家系致病基因的研究

目的 为了解家族性良性天疱疮家系的基因突变方式，以及基因型与临床表型之间的关系。方法 获得临床确诊患者及其家族成员外周血白细胞基因组DNA，设计针对ATP2C1基因的一系列PCR引物，运用单链构象多态性(SSCP)原理筛查此家族性良性天疱疮家系基因突变，用DNA直接测序明确具体的突变位置和方式，分析基因突变的病理意义。结果 此家系存在ATP2C1基因突变，第2068-2076位“TGTAGCCAT”突变成“AGATGGAACA”，造成开放阅读框架移位，出现提前终止密码子，使其编码的蛋白质丢失了一个ATP结合位点和3个钙离子结合位点，丧失了他原有的功能而致病；此家系患者基因型与临床表型无明确关系。结论 ATP2C1基因第21外显子突变是引起本家系家族性良性天疱疮的原因。     

Mutation analysis of ATP2C1 gene in Taiwanese patients with Hailey-Hailey disease

BACKGROUND: Hailey-Hailey disease (HHD) is an autosomal dominant disorder with recurrent eruption of vesicles and bullae involving predominantly the neck, groin and axillary regions. Histopathology shows suprabasal cleavage in epidermal cells. Recent studies have revealed that HHD is caused by mutations in the ATP2C1 gene encoding a novel Ca2+ pump. OBJECTIVES: To analyse the mutations of the ATP2C1 gene in Taiwanese patients with HHD. METHODS: In total, five familial and two sporadic cases of HHD were retrieved from the medical records. The diagnosis of HHD was made based on the characteristic clinical features and histopathological evidence. All 27 exons and flanking intron boundaries were amplified by polymerase chain reaction and products analysed by direct sequencing. RESULTS: We identified six novel mutations and one reported mutation: three deletion mutations (nt884-904del, 1459delCTCA, 1975delA), two non-sense mutations (R39X, R783X), one mis-sense mutation (A730T) and one splicing mutation (483 + 2T-->A). The non-sense mutation R39X had been reported previously; the other six mutations are novel mutations. CONCLUSIONS: These results demonstrate that a spectrum of ATP2C1 gene mutations is present in Taiwanese HHD patients.     

Four novel mutations in ATP2C1 found in Chinese patients with Hailey-Hailey disease

BACKGROUND: Familial benign chronic pemphigus or Hailey-Hailey disease (HHD; OMIM 169600) is an autosomal dominant blistering disease. Pathogenic mutations in ATP2C1 encoding a novel Ca2+ pump have recently been identified. OBJECTIVES: To identify mutations in ATP2C1 in Chinese patients with HHD. METHODS: Eleven unrelated Chinese patients with HHD were subjected to mutation detection in ATP2C1. Eight of them had a family history of HHD. The 27 coding exons and their flanking sequences were amplified and sequenced. RESULTS: Five of the 11 patients were identified to have heterozygous mutations including three nonsense mutations and two splicing mutations in ATP2C1. CONCLUSIONS: Four novel mutations, nonsense mutations S887X and W795X and splicing mutations 118-1 g-->a and 1890+1del(gtgag)ins53, were found in this series of Chinese patients with HHD.     

Mutation analysis of the ATP2C1 gene in Taiwanese patients with Hailey-Hailey disease

BackgroundHailey-Hailey disease (HHD) is an autosomal dominant disorder with recurrent pruritic vesicles and erosions, and scaly erythematous plaques, particularly involving intertriginous areas such as the neck, axillae, groins and perineum. Histopathology shows intraepidermal vesiculation with acantholysis in the suprabasal layer. It is caused by heterozygous mutations in the ATP2C1 gene, which encodes for the human secretory pathway Ca²⁺/Mn²⁺ ATPase 1. In this study, we analyze the mutations of the ATP2C1 gene in 26 Taiwanese patients with HHD.MethodsIn total, 21 familial cases from seven families and 5 sporadic cases (including 7 previously reported) were retrieved from the medical records. The diagnosis of HHD was made based on the characteristic clinical features and histopathological evidence. All 27 exons and flanking intron boundaries were amplified by polymerase chain reaction and the products were analyzed by direct sequencing.ResultsWe identified three nonsense mutations (R39X, R468X, R783X), two splice-site mutations (483 + 2t→a, 832G→A), four deletion mutations (nt884-904del, 1459delCTCA, 1874delA, 1975delA) and one missense mutation (A730T). Two unrelated families with nonsense mutation R783X had the comorbidity of chronic schizophrenia since the third decade.ConclusionsWe report two novel mutations (832G→A and 1874delA) of ATP2C1 involved in HHD. The nonsense mutation R783X might represent a mutational “hotspot” in the ATP2C1 gene. The present study demonstrates that a spectrum of ATP2C1 gene mutations is present in Taiwanese HHD patients.     

Novel mutation in ATP2C1 gene in a Japanese patient with Hailey-Hailey disease

Hailey-Hailey disease (HHD) is an autosomal dominant disorder with recurrent eruption of vesicles and bullae involving predominantly the neck, groin and axillary regions. Histopathology shows suprabasal cleavage in epidermal cells. Recent studies have revealed that HHD is caused by mutations in the ATP2C1 gene encoding a novel Ca(2+) pump. We analyzed mutations of the ATP2C1 gene in 2 Japanese patients with HHD. The diagnosis of HHD was made based on the characteristic clinical features and histopathological evidence. All 27 exons and flanking intron boundaries were amplified by polymerase chain reaction and products analyzed by sequencing. As a result, we identified a novel missense mutation (A1087G) in exon 13 of the ATP2C1 gene in a patient. This mutation led the amino acid change from Thrto Ala in the phosphorylation protein domain. Another patient showed no mutation of the gene. These results demonstrate that a spectrum of ATP2C1 gene mutations is present in Japanese HHD patients.     

Mutations in the ATP2C1 gene in Chinese patients with Hailey-Hailey disease

Hailey-Hailey disease (HHD; MIM 16960) is a rare autosomal dominant hereditary disorder characterized by recurrent eruption of vesicles and bullae, predominantly involving the body folds. It is caused by heterozygous mutations in the ATP2C1 gene, encoding the human secretory pathway Ca2+/Mn2+-ATPase protein 1 (hSPCA1). When we studied Chinese patients with HHD, we found two different heterozygous mutations, Q506X and G353V, the former previously reported in a Hungarian patient, and the latter being a novel mutation. In a 38-year-old patient from a four-generation pedigree with a 3-year history of severe recurrent blisters, we identified a C-->T transition at nucleotide 1696, c(1696C-->T), in exon 17 of ATP2C1, resulting in a nonsenes mutation, Gln506X, which resulted in a premature termination codon. In the second patient, who represented a occurrence of sporadic Hailey-Hailey disease, a G-->T transversion of nucleotide, c(G1238T), in exon 13 of ATP2C1 was detected, which resulted in a Gly353-->Val amino acid substitution (G353V). Our molecular findings further demonstrate that the mutational events in the human ATP2C1 gene encoding the hSPCA1 pump play an important role in the pathogenesis of HHD.     

Detection and comparison of two types of ATP2C1 gene mutations in Chinese patients with Hailey–Hailey disease

The gene ATP2C1 is identified as the defective gene in Hailey–Hailey disease (HHD). The nonsense and missense are two common types of mutations and have ,respectively, been detected in many HHD patients. The aims of our study were to identify the pathogenic ATP2C1 abnormality in Chinese HHD patients, and to compare nonsense and missense mutations in vivo to provide further understanding of the molecular and the physiological basis of HHD. The nucleotide sequencing of the ATP2C1 gene was performed in HHD patients, unaffected family members and 100 unrelated individuals. Meanwhile, we detected and analyzed the clinical manifestations, the expression of ATP2C1 mRNA and hSPCA1 protein in the two types of mutations. Three heterozygous mutations were identified, including a previously reported nonsense mutation (R799X), two novel missense mutations (D644G) and (R417K). The results of comparisons between two types of mutations showed that the common clinical features, the similarly low-level expressions of ATP2C1 mRNA and hSPCA1 protein, but the ATP2C1 mRNA expression of nonsense mutation was lower than missense mutation and even less than half the level of normal people. Our findings expand the known spectrum of ATP2C1 mutations in HHD. We supported the haploinsufficiency theory as prevalent mechanism in both types of mutations, and believed that the differences of ATP2C1 mRNA expressions in peripheral blood may relate with the type of mutation and reflect the state of illness of patients.